Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Johnson and Johnson
Chinese Patent Office
Accenture
Daiichi Sankyo
Argus Health
Healthtrust
Baxter

Generated: August 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,709,392

« Back to Dashboard

Which drugs does patent 8,709,392 protect, and when does it expire?

Patent 8,709,392 protects DIFFERIN and is included in one NDA.

This patent has seventeen patent family members in twelve countries.

Summary for Patent: 8,709,392
Title:Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
Abstract: Cosmetic/dermatological compositions for topical application and useful for the treatment, e.g., of acne, contain, formulated into a physiologically acceptable medium, at least one naphthoic acid compound and at least one polyurethane polymer or derivative thereof, the at least one naphthoic acid compound being dispersed therein.
Inventor(s): Mallard; Claire (Mougins, FR), Ferrara; Eve (Valbonne, FR)
Assignee: Galderma Research & Development (Biot, FR)
Application Number:13/889,163
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form; Process;

Drugs Protected by US Patent 8,709,392

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp DIFFERIN adapalene LOTION;TOPICAL 022502-001 Mar 17, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TREATMENT OF ACNE ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,709,392

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,998,467 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers ➤ Try a Free Trial
8,435,502 Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 8,709,392

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 057866 ➤ Try a Free Trial
Australia 2006290364 ➤ Try a Free Trial
Brazil PI0617045 ➤ Try a Free Trial
Canada 2622468 ➤ Try a Free Trial
China 101262862 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Deloitte
Boehringer Ingelheim
Julphar
Chinese Patent Office
Mallinckrodt
Teva
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.